Clinical Utility of Serum Autoantibodies Detected by Protein Microarray in Melanoma
Open Access
- 19 October 2011
- journal article
- research article
- Published by Wiley in International Journal of Proteomics
- Vol. 2011, 1-9
Abstract
Better prognostic and predictive markers in melanoma are needed to select patients for therapy. We utilized a dual-lectin affinity chromatography and a natural protein microarray-based analysis to select a subproteome of target glycoproteins to profile serum antibodies against melanoma associated antigens that may predict nodal positivity. We identified 5 melanoma-associated antigens using this microarray coupled to mass spectrometry; GRP75, GRP94, ASAH1, CTSD and LDHB. We evaluated their predictive value for nodal status adjusting for age, gender, Breslow thickness, mitotic rate and ulceration using standard logistic regression. After adjustment, ASAH1, CTSD and LDHB were significantly negatively associated with nodal status (P = 0.0008) and GRP94 was significantly positively associated (P = 0.014). Our best multivariate model for nodal positivity included Breslow thickness, presence of serum anti-ASAH1, anti-LDHB or anti-CTSD, and presence of serum anti-GRP94, with an area under the ROC curve of 0.869. If validated, these results show promise for selecting clinically node negative patients for SLN biopsy. In addition, there is strong potential for glycoprotein microarray to screen serum autoantibodies that may identify patients at high risk of distant metastases or those likely or unlikely to respond to treatment, and these proteins may serve as targets for intervention.Keywords
Funding Information
- National Cancer Institute (R01CA106402, R21CA124441)
- National Cancer Institute (R01CA106402, R21CA124441)
- Merck (R01CA106402, R21CA124441)
- Whitehouse Station, New Jersey (R01CA106402, R21CA124441)
- University of Michigan (R01CA106402, R21CA124441)
This publication has 37 references indexed in Scilit:
- Serum Autoantibody Profiling Using a Natural Glycoprotein Microarray for the Prognosis of Early MelanomaJournal of Proteome Research, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancerClimacteric, 2009
- Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapyExpert Opinion on Therapeutic Targets, 2009
- Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential RadiosensitizerMolecular Therapy, 2009
- Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic MelanomaCancer Investigation, 2008
- HSP90 as a marker of progression in melanomaAnnals of Oncology, 2007
- Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatmentsEuropean Journal of Cancer, 2002
- Roles for glycosylation of cell surface receptors involved in cellular immune recognitionJournal of Molecular Biology, 1999
- Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumoursArchives of Dermatological Research, 1995